Good MorningThe S&P 500 pulled back on Thursday following better-than-expected results from Walmart. The world's largest retailer reported top and bottom-line outperformance driven by strength in all categories. The bad news is that guidance is weak and forecasts growth to slow. The result is a 6% decline in WMT's share price and market top that may remain in place until later this year.
Next week could be a volatile one for the S&P 500. The market faces earnings reports from numerous retailers and a critical economic release due Friday. The January read of the PCE price index is due and likely to confirm sticky inflation. The market could enter a correction in this scenario due to the impact on the FOMC rate reduction timeline. The FOMC is expected to lower interest rates, but the timing is uncertain and may not be until 2026. Featured: Is Elon's empire crumbling? (Ad) 
|
Markets | | |
One of the most important things investors need to be aware of in the market is economic data, especially when the S&P 500 trades near or at its all-time highs, such as today. This is because the data will show investors what the charts won’t and that is whether the underlying economy ca... Read the Full Story |
|
From Our Partners | | Tesla's About to Prove Everyone Wrong... Again
Back in 2018, when Jeff Brown told everyone to buy Tesla…
The "experts" said Elon was finished and Tesla was headed for bankruptcy.
Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. | | Click here to see why Tesla's about to prove everyone wrong... again. |
|
Stocks | | | U.S. stocks fell sharply Friday after reports showed that worries among consumers and businesses about President Donald Trump’s policies may be hitting the U.S. economy. The S&P 500 sank 1.7% for its worst day in two months. The Dow Jones Industrial Average dropped 748 points, or 1.7%, and the N... Read the Full Story |
|
Markets | | |
High-profile stock market stories tend to carry a stigma for investors in the sense that few know whether it’s best to trade these names or just hold them for the long haul. Today, the largest share of attention and capital is centered around the technology sector in the United States, par... Read the Full Story |
|
From Our Partners | | Cold War Discovery Could Unlock $100 Trillion in Wealth
Jeff recently traveled to an American ghost town to investigate this crazy Cold War story…
Because it could hold the key to the entire $100 trillion AI boom.
It involves an American ghost town with just 30 people…
And a new twist to the AI boom that could make a lot of people rich. | | Click here to see the details on what could be the biggest tech story of this decade. |
|
Stocks | | | A sharp slide for Walmart on Thursday helped pull Wall Street off of its record.The S&P 500 slipped 0.4% for its first drop after setting all-time highs in each of the last two days. The Dow Jones Industrial Average lost 450 points, or 1%, and the Nasdaq composite sank 0.5%. Walmart drove the ma... Read the Full Story |
|
Markets | | |
Bridgewater Associates, founded by famed investor Ray Dalio, loaded up on shares of some big-name stocks in Q4. Bridgewater Associates recently released its Form 13F. Institutional investment managers with more than $100 million in discretionary control over 13F Securities must file this document.... Read the Full Story |
|
From Our Partners | | CPA and CFA says you have WAY too many stocks - just buy these 3
After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%. | | Click here to view… |
|
Markets | | |
Tesla Inc. (NASDAQ: TSLA) has had a wild ride over the past few months. In the weeks following Trump’s election victory, the stock soared 130%, reaching an all-time high in December before momentum stalled. Since then, shares have fallen more than 25%, with investors taking profits an... Read the Full Story |
|
Markets | | | Walmart delivered another year of strong sales and profits with its competitive prices an increasingly strong magnet for inflation-weary shoppers, but this year appears to come with new challenges in an uncertain economic landscape Read the Full Story |
|
Markets | | |
Walmart's (NYSE: WMT) February price correction is a buying signal for long-term investors. The drop is due to slowing growth and tariff fears but does little to alter the long-term outlook for earnings, cash flow, equity gains, and capital return. While slower growth and tariffs are headwi... Read the Full Story |
|
Markets | | | Giant wind turbines tower over a cemetery sacred to Zoyla Velasquez and her Indigenous Wayuu community, native to the La Guajira region in northern Colombia.This arid, wind-swept region, dotted with cacti and roaming herds of goats, holds immense potential to position Colombia as a wind and solar en... Read the Full Story |
|
Markets | | | Inflation in the U.K. rose to a 10-month high in January, official figures showed Wednesday, an increase that will likely diminish expectations of rapid interest rate reductions from the Bank of England.The Office for National Statistics said inflation, as measured by the consumer prices index, rose... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. | Should I Buy Merck & Co., Inc. Stock? MRK Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Merck & Co., Inc. was last updated on Monday, July 14, 2025 at 6:22 PM.
Merck & Co., Inc. Bull Case -
The current stock price is around $83.80, which reflects a stable market position and potential for growth.
-
Merck recently reported earnings per share that exceeded analyst expectations, indicating strong financial performance and effective management.
-
The company has a solid dividend yield of approximately 3.87%, providing a reliable income stream for investors.
-
Merck's market capitalization is around $210 billion, showcasing its significant presence in the pharmaceutical industry and potential for long-term stability.
-
Recent analyst ratings suggest a generally positive outlook, with several firms maintaining buy ratings, indicating confidence in the company's future performance.
Merck & Co., Inc. Bear Case -
The company's revenue has shown a slight decline year-over-year, which may raise concerns about future growth prospects.
-
Some analysts have downgraded their ratings, reflecting caution regarding Merck's market performance and potential challenges ahead.
-
Merck's stock has experienced volatility, with a 52-week high of $129.03 and a low of $73.31, indicating potential risks for investors.
-
The debt-to-equity ratio of 0.69 suggests that the company has a moderate level of debt, which could impact financial flexibility in challenging market conditions.
-
Insider selling activity has been noted, which may signal a lack of confidence among company executives regarding future performance.
| | View Today's Stock Pick |
|
